These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25500308)

  • 21. Transplacental transmission of BTV-8 in sheep: BTV viraemia, antibody responses and vaccine efficacy in lambs infected in utero.
    van der Sluijs MT; Schroer-Joosten DP; Fid-Fourkour A; Smit M; Vrijenhoek MP; Moulin V; de Smit AJ; Moormann RJ
    Vaccine; 2013 Aug; 31(36):3726-31. PubMed ID: 23746457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of cross-protection induced by a bluetongue virus (BTV) serotype 8 vaccine towards other BTV serotypes in experimental conditions.
    Martinelle L; Dal Pozzo F; Thys C; De Leeuw I; Van Campe W; De Clercq K; Thiry E; Saegerman C
    Vet Res; 2018 Jul; 49(1):63. PubMed ID: 30012223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
    Stewart M; Dubois E; Sailleau C; Bréard E; Viarouge C; Desprat A; Thiéry R; Zientara S; Roy P
    Vaccine; 2013 Jan; 31(3):553-8. PubMed ID: 23159460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bluetongue viruses based on modified-live vaccine serotype 6 with exchanged outer shell proteins confer full protection in sheep against virulent BTV8.
    van Gennip RG; van de Water SG; Maris-Veldhuis M; van Rijn PA
    PLoS One; 2012; 7(9):e44619. PubMed ID: 23049753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge.
    Wade-Evans AM; Romero CH; Mellor P; Takamatsu H; Anderson J; Thevasagayam J; Fleming MJ; Mertens PP; Black DN
    Virology; 1996 Jun; 220(1):227-31. PubMed ID: 8659119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
    Roy P; Bishop DH; LeBlois H; Erasmus BJ
    Vaccine; 1994 Jul; 12(9):805-11. PubMed ID: 7975859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bluetongue virus RNA detection by RT-qPCR in blood samples of sheep vaccinated with a commercially available inactivated BTV-8 vaccine.
    Steinrigl A; Revilla-Fernández S; Eichinger M; Koefer J; Winter P
    Vaccine; 2010 Aug; 28(34):5573-81. PubMed ID: 20600511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viraemia and clinical disease in Dorset Poll sheep following vaccination with live attenuated bluetongue virus vaccines serotypes 16 and 4.
    Veronesi E; Darpel KE; Hamblin C; Carpenter S; Takamatsu HH; Anthony SJ; Elliott H; Mertens PP; Mellor PS
    Vaccine; 2010 Feb; 28(5):1397-403. PubMed ID: 19895921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine.
    Oura CA; Wood JL; Floyd T; Sanders AJ; Bin-Tarif A; Henstock M; Edwards L; Simmons H; Batten CA
    Vaccine; 2010 Mar; 28(15):2749-53. PubMed ID: 20123052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
    Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of a Bluetongue inactivated vaccine (serotypes 1 and 4) in sheep.
    Bamouh Z; Es-Sadeqy Y; Safini N; Douieb L; Omari Tadlaoui K; Martínez RV; García MA; Fassi-Fihri O; Elharrak M
    Vet Microbiol; 2021 Oct; 261():109212. PubMed ID: 34450450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interference of colostral antibodies with response to a Bluetongue serotype 8 inactivated vaccine in lambs born from hyperimmune ewes.
    Leemans J; Hamers C; Chery R; Bibard A; Besancon L; Duboeuf M; Hudelet P; Goutebroze S; Kirschvink N
    Vaccine; 2013 Apr; 31(15):1975-80. PubMed ID: 23422141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
    Kochinger S; Renevey N; Hofmann MA; Zimmer G
    Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic response of sheep to inactivated and virulent bluetongue virus.
    Stott JL; Barber TL; Osburn BI
    Am J Vet Res; 1985 May; 46(5):1043-9. PubMed ID: 2988376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle.
    Hamers C; Galleau S; Chery R; Blanchet M; Besancon L; Cariou C; Werle-Lapostolle B; Hudelet P; Goutebroze S
    Vet Rec; 2009 Sep; 165(13):369-73. PubMed ID: 19783850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines for Prevention of Bluetongue and Epizootic Hemorrhagic Disease in Livestock: A North American Perspective.
    McVey DS; MacLachlan NJ
    Vector Borne Zoonotic Dis; 2015 Jun; 15(6):385-96. PubMed ID: 26086559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A one-year follow-up of antibody response in cattle and sheep after vaccination with serotype 8- and serotype 1-inactivated BT vaccines.
    Zanella G; Bréard E; Sailleau C; Zientara S; Viarouge C; Durand B
    Transbound Emerg Dis; 2014 Oct; 61(5):473-6. PubMed ID: 23331382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine prime and recombinant FPV vaccine boost: an important candidate immunization strategy to control bluetongue virus type 1.
    Li J; Yang T; Xu Q; Sun E; Feng Y; Lv S; Zhang Q; Wang H; Wu D
    Appl Microbiol Biotechnol; 2015 Oct; 99(20):8643-52. PubMed ID: 26048472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.